替格瑞洛在老年急性冠脉综合征患者中应用的临床疗效观察(3)
[2]Soo Hoo SY , Gallagher R , Elliott D. Systematic review of health-related quality of life in older people following percutaneous coronary intervention[J].Nurs Health Sci,2014,16 (4): 415-427.
[3]Gillis NK , Arslanian-Engoren C , Struble LM. Acute coronary syndromes in older adults: a review of literature[J].J Emerg Nurs,2014,40 (3): 270-275.
[4]Kang HJ , Clare RM , Gao R, et al. Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial[J].Am Heart J,2015,169 (6): 899-905.
[5]Davis LL. Cardiovascular issues in older adults[J].Crit Care Nurs Clin North Am,2014,26 (1): 61-89.
[6]Iung B , Rodés-Cabau J. The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertainties. Eur Heart J,2014,35 (42): 2942-2949.
[7]Schreiber P , Fauchère I , Wyss C. Using ADP receptor antagonists in coronary heart disease and acute coronary syndrome[J].Praxis (Bern 1994),2014,103 (18): 1049-1058.
[8]Saunderson CE , Brogan RA , Simms AD, et al. Acute coronary syndrome management in older adults: guidelines, temporal changes and challenges[J].Age Ageing,2014,43 (4): 450-455.
[9]Fanari Z , Weiss S , Weintraub WS. Cost Effectiveness of Antiplatelet and Antithrombotic Therapy in the Setting of Acute Coronary Syndrome: Current Perspective and Literature Review[J].Am J Cardiovasc Drugs,2015,15 (6): 415-427.
[10]De Luca L , Danchin N , Valgimigli M, et al. Effectiveness of Pretreatment With Dual Oral Antiplatelet Therapy[J].Am J Cardiol ,2015 ,116 (4): 660-668.
編辑/金昊天, 百拇医药(李勇 王铭)
[3]Gillis NK , Arslanian-Engoren C , Struble LM. Acute coronary syndromes in older adults: a review of literature[J].J Emerg Nurs,2014,40 (3): 270-275.
[4]Kang HJ , Clare RM , Gao R, et al. Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial[J].Am Heart J,2015,169 (6): 899-905.
[5]Davis LL. Cardiovascular issues in older adults[J].Crit Care Nurs Clin North Am,2014,26 (1): 61-89.
[6]Iung B , Rodés-Cabau J. The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertainties. Eur Heart J,2014,35 (42): 2942-2949.
[7]Schreiber P , Fauchère I , Wyss C. Using ADP receptor antagonists in coronary heart disease and acute coronary syndrome[J].Praxis (Bern 1994),2014,103 (18): 1049-1058.
[8]Saunderson CE , Brogan RA , Simms AD, et al. Acute coronary syndrome management in older adults: guidelines, temporal changes and challenges[J].Age Ageing,2014,43 (4): 450-455.
[9]Fanari Z , Weiss S , Weintraub WS. Cost Effectiveness of Antiplatelet and Antithrombotic Therapy in the Setting of Acute Coronary Syndrome: Current Perspective and Literature Review[J].Am J Cardiovasc Drugs,2015,15 (6): 415-427.
[10]De Luca L , Danchin N , Valgimigli M, et al. Effectiveness of Pretreatment With Dual Oral Antiplatelet Therapy[J].Am J Cardiol ,2015 ,116 (4): 660-668.
編辑/金昊天, 百拇医药(李勇 王铭)